Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 17, 2021 - Issue
Submit an article Journal homepage
92
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Early Improvement of Psychiatric Symptoms with Long-Acting Injectable Antipsychotic Predicts Subsequent Social Functional Remission in Patients with Schizophrenia

Takashi Ohnishi1 Medical Affairs Division, Janssen Pharmaceutical K.K., Tokyo, JapanCorrespondence[email protected]
View further author information
,
Akihide Wakamatsu1 Medical Affairs Division, Janssen Pharmaceutical K.K., Tokyo, JapanORCID Iconhttps://orcid.org/0000-0001-8551-8324View further author information
ORCID Icon &
Hisanori Kobayashi2 Research and Development Clinical Science Division, Janssen Pharmaceutical K.K., Tokyo, JapanView further author information
Pages 1095-1104 | Published online: 16 Apr 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.